DELFI Diagnostics to Present Innovative Advances in Cancer Detection at AACR 2026 Annual Meeting At the AACR 2026, DELFI Diagnostics will unveil recent innovations in cancer detection using whole-genome cfDNA, covering lung cancer sustyping and treatment response.

DELFI Diagnostics to Present Innovative Advances in Cancer Detection at AACR 2026 Annual Meeting #United_States #San_Diego #DELFI_Diagnostics #cancer_detection #cfDNA_advances

DELFI Diagnostics Names Cindy Soriano CFO; Joins J.P. Morgan Healthcare Conference Cindy Soriano has been appointed CFO of DELFI Diagnostics, with CEO Susan Tousi set to present at the J.P. Morgan Healthcare Conference in January.

DELFI Diagnostics Names Cindy Soriano CFO; Joins J.P. Morgan Healthcare Conference #United_States #Palo_Alto #J.P._Morgan #DELFI_Diagnostics #Cindy_Soriano

Preliminary Findings of FANSS Study Highlight Blood-Based Lung Cancer Screening for Non-Smokers Delving into the results of the FANSS study, researchers reveal potential for blood-based lung cancer screening in Asian women who do not smoke, addressing a significant health concern.

Preliminary Findings of FANSS Study Highlight Blood-Based Lung Cancer Screening for Non-Smokers #USA #Palo_Alto #DELFI_Diagnostics #Lung_Cancer #FANSS_Study

DELFI Diagnostics CTO Dr. Amoolya Singh Honored as Influential Leader in Bay Area Dr. Amoolya Singh, CTO of DELFI Diagnostics, has been named one of the most influential women in Bay Area business for 2025.

DELFI Diagnostics CTO Dr. Amoolya Singh Honored as Influential Leader in Bay Area #United_States #Palo_Alto #DELFI_Diagnostics #Amoolya_Singh #cancer_detection

DELFI Diagnostics Unveils Breakthrough Cancer Monitoring and Detection at AACR Annual Meeting DELFI Diagnostics is set to showcase its early detection and cancer monitoring technologies at the AACR Annual Meeting, highlighting advancements in fragmentomics.

DELFI Diagnostics Unveils Breakthrough Cancer Monitoring and Detection at AACR Annual Meeting #United_States #Chicago #DELFI_Diagnostics #cancer_detection #fragmentomics

DELFI Diagnostics Set to Make Waves at J.P. Morgan Healthcare Conference 2025 DELFI Diagnostics is scheduled to present at the J.P. Morgan Healthcare Conference, showcasing innovative blood-based cancer detection tests.

DELFI Diagnostics Set to Make Waves at J.P. Morgan Healthcare Conference 2025 #USA #San_Francisco #J.P._Morgan #DELFI_Diagnostics #cancer_detection

DELFI Diagnostics Appoints Dr. Amoolya Singh as New CTO to Advance Cancer Diagnostics DELFI Diagnostics elevates Dr. Amoolya Singh as Chief Technology Officer to lead innovations in blood-based cancer detection technology, enhancing early diagnosis capabilities.

DELFI Diagnostics Appoints Dr. Amoolya Singh as New CTO to Advance Cancer Diagnostics #United_States #Baltimore #Cancer_Diagnostics #DELFI_Diagnostics #Amoolya_Singh